Opinion: The real Chris Collins scandal: lax conflict-of-interest rules in Congress

When it comes to recusing themselves from decisions that implicate their financial interests or divesting assets, members of Congress play by their own rules.
Rep. Chris Collins (R-N.Y.) walks out of a New York City courthouse after being charged with insider trading on Aug. 8. Source: Spencer Platt/Getty Images)

In the aftermath of Rep. Chris Collins’ (R-N.Y.) arrest last week on insider trading charges stemming from his involvement with an Australian biotech company, it is tempting to focus public attention and anger on his alleged crimes. But we should be far more concerned by what the episode reveals about Congress’ failure to regulate members’ financial conflicts of interest.

It’s certainly troubling that Collins may have broken the law. It’s even more troubling that he was allowed to invest in a biotech company and sit

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readSociety
With The Pandemic Sidelining Routine Care, A Trade Group Urges The Government To Pay For Digital Therapeutics
A prominent trade group is urging the government to expand access to digital health tools for Medicare and Medicaid enrollees during the #coronavirus pandemic.
STAT2 min readSociety
Coronavirus-related Layoffs Hit Health Tech Startups
The cuts underscore that not even digital health — an industry whose offerings are in high demand during the crisis — is immune to an unprecedented financial meltdown.
STAT3 min readPolitics
Trump Pledges To Put A Hold On U.S. Funding For The World Health Organization
President Trump said he'd put a hold on the U.S. government's contributions to the World Health Organization.